Immunogenicity of variable regions of hepatitis C virus proteins:: selection and modification of peptide epitopes to assess hepatitis C virus genotypes by ELISA

被引:20
作者
Rodríguez-López, M [1 ]
Riezu-Boj, JI [1 ]
Ruiz, M [1 ]
Berasain, C [1 ]
Civeira, MP [1 ]
Prieto, J [1 ]
Borrás-Cuesta, F [1 ]
机构
[1] Univ Navarra, Fac Med, Dept Med Interna, E-31080 Pamplona, Spain
关键词
D O I
10.1099/0022-1317-80-3-727
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
The immunogenicity of variable regions of hepatitis C virus (HCV) proteins was studied by ELISA by using 543 synthetic peptides from 120 variable regions and 90 sera from HCV-infected patients. Some regions from certain genotypes were less immunogenic, or even non-immunogenic, compared with their equivalents in other genotypes, However, the mean recognition of all peptides from genotypes 1a, 1b and 3 by sera infected with genotypes la, Ib and 3, respectively, showed no significant differences, suggesting a similar overall immunogenicity of variable regions from these genotypes, Proteins NS4a, NS4b and NS5a were found to be the most immunogenic, Recognition of individual peptides by the sera of infected patients showed that the humoral response against HCV is patient-dependent. The work shows that 15-mer peptides may encompass several B-cell epitopes, These epitopes may lie in slightly different positions in different genotypes, Thirty-one percent of the 543 peptides were recognized by some of the 35 healthy donors. This may be a reflection of the large number of antigens to which they had been exposed, but it may also reflect a strategy of HCV to respond to immune pressure. After selection and modification, a set of 40 peptides was used to assess genotypes 1a, 1b, 1, 2 and 3 in the sera of HCV-infected patients, with sensitivities of 34.1, 48.5, 68.8, 58.3 and 48.9% and specificities of 100, 99.1, 97.1, 99.5 and 99%, respectively. The overall sensitivity and specificity for the assessment of genotypes 1, 2 and 3 were 64 and 98%, respectively.
引用
收藏
页码:727 / 738
页数:12
相关论文
共 58 条
[1]  
*AG MED FRANC, 1996, DRUG AG EV RIB SER V
[2]  
ALTER HJ, 1989, CURRENT PERSPECTIVES, P83
[3]  
Atherton E., 1981, J CHEM SOC P1, V1, P538
[4]   Genotype, viral load and age as independent predictors of treatment outcome of interferon-alpha 2a treatment in patients with chronic hepatitis C [J].
Bell, H ;
Hellum, K ;
Harthug, S ;
Maeland, A ;
Ritland, S ;
Myrvang, B ;
VonderLippe, B ;
Raknerud, N ;
Skaug, K ;
Gutigard, BG ;
Skjaerven, R ;
Prescott, LE ;
Simmonds, P ;
Bucher, A ;
Lind, E ;
Schulz, T ;
Sundoy, A ;
Barstad, S ;
Storseth, P ;
Nordoy, I ;
Bjark, P ;
Anfinsen, OG ;
Klem, K ;
Stray, N ;
Weberg, R ;
Melsom, M ;
Mosvold, J ;
Haug, J ;
Langtind, J ;
Wetterhus, S ;
Ostborg, J ;
Aadland, E ;
Mowe, M ;
Jahnsen, J ;
Muller, F .
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 1997, 29 (01) :17-22
[5]   DETECTION OF ANTI-HEPATITIS-C VIRUS-ANTIBODIES BY ELISA USING SYNTHETIC PEPTIDES [J].
BERASAIN, C ;
GARCIAGRANERO, M ;
RIEZUBOJ, JI ;
CIVEIRA, MP ;
PRIETO, J ;
BORRASCUESTA, F .
JOURNAL OF HEPATOLOGY, 1993, 18 (01) :80-84
[6]   INSIGHTS ON THE AMINO-ACID SIDE-CHAIN INTERACTIONS OF A SYNTHETIC T-CELL DETERMINANT [J].
BORRASCUESTA, F ;
GOLVANO, J ;
SAROBE, P ;
LASARTE, JJ ;
PRIETO, I ;
SZABO, A ;
GUILLAUME, JL ;
GUILLET, JG .
BIOLOGICALS, 1991, 19 (03) :187-190
[7]   ENHANCEMENT OF PEPTIDE IMMUNOGENICITY BY LINEAR POLYMERIZATION [J].
BORRASCUESTA, F ;
FEDON, Y ;
PETITCAMURDAN, A .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1988, 18 (02) :199-202
[8]   Hepatitis C virus - Molecular biology and genetic variability [J].
Brechot, C .
DIGESTIVE DISEASES AND SCIENCES, 1996, 41 (12) :S6-S21
[9]   AT LEAST 12 GENOTYPES OF HEPATITIS-C VIRUS PREDICTED BY SEQUENCE-ANALYSIS OF THE PUTATIVE E1-GENE OF ISOLATES COLLECTED WORLDWIDE [J].
BUKH, J ;
PURCELL, RH ;
MILLER, RH .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (17) :8234-8238
[10]   Comparative evaluation of two serologic typing methods for hepatitis C virus [J].
Cerino, A ;
Cividini, A ;
Asti, M ;
Lanza, A ;
Silini, E ;
Mondelli, MU .
JOURNAL OF CLINICAL MICROBIOLOGY, 1996, 34 (03) :714-716